Myocardial infarction in Fabry disease – misfortune or companion? Case report and review of the literature
Journal Title: Journal of Rare Cardiovascular Diseases - Year 2018, Vol 3, Issue 7
Abstract
We discuss a 56‑year‑old man with Fabry disease (FD), a genetic X‑linked glycolipid storage disorder. The patient presented at the Emergency Room in a local hospital due to tachycardia‑associated chest pain, which had occurred occasionally in the past, but on that occasion was long‑lasting (>12h) and distressing. The patient had been diagnosed with FD at the age of 42. He presented a range of symptoms characteristic for the condition, including hypertrophic cardiac myopathy with impaired left ventricular relaxation, angiokeratomas, cornea verticillata, hypohydrosis and acroparesthesia. Residual alpha‑galactosidase A activity at diagnosis was ≈3%. The Enzyme Replacement Therapy (ERT) with the agalsidase alpha was induced. A year later pacemaker implantation was performed due to sick sinus syndrome with symptomatic, severe episodes of bradycardia. The initial diagnosis was tachycardia‑associated chest pain with troponin release in the context of FD left ventricular hypertrophy. However, a decision was made to perform an urgent angiographic evaluation to exclude coronary pathology as a potential factor in the clinical picture. Coronary angiography showed a critical, flow-limiting, stenosis of the left anterior descending artery (LAD) which changed the initial type 2 myocardial infarction (MI) diagnosis to the type 1 MI. Percutaneous stent‑assisted treatment was performed with an optimal angiographic and clinical outcome. However, 5 days later the patient developed a minor left hemispheric ischaemic stroke. In conclusion, the clinical course of a rare pathology such as FD may be importantly complicated by other (more common) pathologies. Physicians, in their diagnostic and therapeutic decision‑making, need to be open to thinking beyond the patient label. JRCD 2018; 3 (7): 246–252
Authors and Affiliations
Jakub Chmiel, Maciej Skubera, Jacek Bednarek, Klaudia Knap, Marta Swarowska‐Skuza, Stanisława Bazan‐Socha, Adam Mazurek, Lidia Tomkiewicz‐Pająk, Maria Olszowska, Piotr Podolec
Keywords
Related Articles
- EP ID EP387104
- DOI 10.20418/jrcd.vol3no7.335
- Views 100
- Downloads 0
Common problems in rare congenital heart diseases
Congenital heart disease (CHD) is the most common developmental anomaly and is found in about 1% of all live-born children.Recent progress in cardiac surgery and pediatric cardiology hasresulted in large numbers of adult...
A 23‑year‑old woman with Marfan syndrome and spine deformity (RCD code: I-2A.1)
Marfan syndrome is one of the most common heritable connective tissue disorders that is caused by various mutations of the Fibrillin-1(FBN1) gene. The cardinal features of Marfan syndrome are aortic root dilatation and e...
Female patient after correction of tetralogy of Fallot with severe pulmonary regurgitation and significant left-to-right shunt at the ventricular septal level (RCD code: IV-5A2)
Tetralogy of Fallot (ToF) is the most common cyanotic congenital heart disease after 1 year of age. Less than 5% of all patients with uncorrected ToF live beyond the age of 40 years. Prognosis after surgical correction i...
World Rare Disease Day – 29th of February 2016 III Conference of Rare Cardiovascular Diseases at John Paul II Hospital in Krakow
The third Conference of Rare Cardiovascular Diseases took place at the John Paul II Hospital in Krakow, Poland on the 29th of February 2016. The conference was organized as part of the World Rare Disease Day 2016 annuall...
Cardiac manifestations in a two‑generation family with Fabry disease (RCD code: III‑2B.2a)
Fabry disease (FD), which is also called angiokeratoma corporis difusum, ceramide trihexosidosis, and Anderson-Fabry disease, is an X-linked inborn error of metabolism of glycosphingolipid pathway. It is caused by the de...